Chronic Lymphocytic Leukemia Excellence Forum

Chronic Lymphocytic Leukemia

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Videos

Dr Kittai Discusses the Impact of Complex Karyotype for Patients With CLL Treated With Ibrutinib

10/19/2021

Adam Kittai, MD, Assistant Professor, The Ohio State University, discusses a study on the impact of complex karyotype in patients with CLL treated with ibrutinib.

Adam Kittai, MD, Assistant...

10/19/2021

Oncology

Videos

Dr Elnair Discusses Richter's Transformation Outcomes for Patients With CLL/SLL

10/07/2021

Radowan A Elnair, MD, discusses a study on the outcome of Richter’s transformation in patients with CLL and SLL.

Radowan A Elnair, MD, discusses...

10/07/2021

Oncology

Videos

Dr Cheung Discusses Ibrutinib-Based Regimens Versus Standard CIT for CLL

09/30/2021

Matthew Cheung, MD, FRCPC, SM, discusses a trial comparing bendamustine-rituximab with ibrutinib-based regimens in untreated patients with CLL.

Matthew Cheung, MD, FRCPC, SM,...

09/30/2021

Oncology

Videos

RIC-HSCT Yields Favorable Outcomes for Patients With CLL-RT

09/21/2021

Oscar B. Lahoud, MD, discusses RIC-HSCT for patients with high-risk CLL and RT.

Oscar B. Lahoud, MD, discusses...

09/21/2021

Oncology

Interview

Dr van der Straten Discusses the Risk for SPMs in CLL

08/17/2021

Lina van der Straten, MD, PhD, spoke on the findings and significance of a nationwide, population-based study on the risk for SPM development in CLL.

Lina van der Straten, MD, PhD,...

08/17/2021

Oncology

Videos

MRD-Driven Therapy With Ibrutinib Plus Venetoclax for R/R CLL

08/12/2021

Lydia Scarfò, MD, discusses an MRD-driven treatment strategy with ibrutinib and venetoclax for R/R CLL. These data were presented at the 2021 EHA Virtual Congress.

Lydia Scarfò, MD, discusses an...

08/12/2021

Oncology

Interview

Case Study Shows Success of Ibrutinib for CLL/SLL After Allo-HSCT

08/11/2021

Masatoshi Sakurai, MD, PhD, discusses the successful use of ibrutinib in a patient with CLL/SLL who had CNS relapse approximately 10 years after allo-HSCT.

Masatoshi Sakurai, MD, PhD,...

08/11/2021

Oncology

Interview

David Frank, MD, PhD, on Targeting STAT3 in CLL

07/28/2021

Dr Frank discusses the findings and significance of a clinical trial on the use of STAT3 inhibitor pyrimethamine in patients with CLL.

Dr Frank discusses the findings...

07/28/2021

Oncology

Interview

Jennifer Woyach, MD, Discusses How to Best Sequence Regimens for Patients with R/R CLL

07/15/2021

Jennifer Woyach, MD, shares an update on how to best sequence available regimens for the management of patients with R/R CLL.

Jennifer Woyach, MD, shares an...

07/15/2021

Oncology

Videos

Imbruvica–Venetoclax Combo Demonstrates Superior PFS in CLL

06/30/2021

Arnon P. Kater, MD, PhD, discusses findings from the phase 3 GLOW study of imbruvica plus venetoclax for CLL, the data of which were presented at the EHA2021 Virtual Congress.

Arnon P. Kater, MD, PhD,...

06/30/2021

Oncology

Chronic Lymphocytic Leukemia Excellence Forum

Specialties

Events

Year Round Education

HMP Global Products